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 Support vector machine (SVM) has been applied successfully in biological 
systems for prediction of various biological properties, functions and features. 
While the generalization property of SVM is a crucial factor in its success as a 
classifier, the choice of feature vector is equally important. Feature vectors should 
contain informative descriptions that can correctly distinguish data classes. For 
prediction in any biological system, feature vectors should be chosen based on a 
clear understanding of these systems. 
I describe two novel prediction methods that employ the generalization 
property of support vector machine: 1. A cross-reactive allergen prediction 
method based on pairwise sequence similarity, AllerHunter. This tool addresses 
the limited ability of existing prediction methods to distinguish allergen-like non-
allergens from true allergens. 2. A viral sequence prediction method called VIPR, 
based on codon usage indices. This tool addresses the specific challenge of 
assessing unknown sequence samples, obtained within projects aiming to discover 
novel disease agents and mapping of the human virome. VIPR is currently a 
unique tool of which there is no other tool of the same genre to compare with. 
AllerHunter performs significantly better than the leading cross-reactive 
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One the main challenges in computational biology is the extraction of useful 
information from the exponentially growing amount of biological data. These data 
are typically multidimensional and noisy. To make sense of the data, various 
methods have been applied. Machine Learning techniques in particular, have 
gained popularity due to their ability to learn and continuously improve from 
experience. Another important advantage of using Machine Learning techniques 
compared to standard statistical methods is their ability to model non-linear 
relationships. Some well-known techniques are Fisher linear discriminant analysis 
(Fisher 1936), artificial neural networks (McCulloch and Pitts, 1943), nearest-
neighbour rule (Fix and Hodges, 1951), Bayesian classifiers (Duda and Hart, 
1973), hidden Markov model (Baum and Petrie, 1966) and support vector 
machines (Vapnik, 1995).  
The classification of data using Machine Learning techniques involves a 
search of functions that map selected features to relevant data classes. Relevant 
data classes can be for example coding and non-coding DNA sequences. The 
classification process will always incorporate errors. In order to achieve a good 
performance, it is important to try to minimize the errors. Comparisons of 
performance with other methods show that SVM either matches or is significantly 
better than other methods (Müller et al., 1997; Murkherjee et al., 1997; Drucker et 
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al., 1997; Vapnik et al., 1996; Brown et al., 2000). SVM minimizes the error in 
data classification, known as the structural risk by finding a unique hyper-plane 
with maximum margin to separate the data classes (Vapnik, 1995).  This gives 
SVM the advantage of having the best generalization ability on unseen data 
compared to other classifier methods (Zheng 2004). Other advantages of SVM are 
1. SVM has a global optimum solution and does not suffer from local minima 
(Burgess 1998, Abe 2005) 2. margin parameter in SVM controls misclassification 
error by suppressing outliers (Abe 2005) 3. SVM have a simple geometric 
interpretation that gives sparse solution, 4. SVM are less prone to overfitting to 
other methods such as neural networks.  
Specifically, this project aims to: 1. Test if pairwise sequence similarity 
scores can be used as features vectors to predict allergen cross-reactivity. 2. Test 
the hypothesis that the difference in codon usage in different species can be used 
to predict the origin of sequences. Focus is on the viral sequences. 3. Implement 
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1.1 Support Vector Machine  
SVM was developed as a binary classification method by Vapnik et al. in 1995. 
Since then, SVM has been applied to classification across different fields i.e. 
environmental science (Kanevski et al., 2004) and facial expression classification 
(Ghent and McDonald, 2005), as well as bioinformatics (Rangwala and Karypis, 
2005, Lian et al., 2004; Ying et al 2004a; Ying et al, 2004b,).  
SVM aims to minimize the expectation of the output of sampling error. 
Given a set of binary-labeled training data, SVM maps the data onto a high 
dimensional feature space and defines a boundary, which separates the two 
classes of data with a maximum margin by locating a weight vector w and a 
threshold for ƒ(x) and b thereby giving good generalization properties. The 
decision boundary is defined by the function in Eq. 1 
! 
f (x) = w " x + b        (1) 
where feature vector x of a sample is classified into either positive or negative 
data set. Support vectors are samples closest to the hyperplane and are crucial for 
training.  
 In many cases, samples of different classes cannot be effectively separated 
by a linear function in the original feature space. Thus, feature vectors are mapped 
into a high dimensional space by a function φ such that a linear maximum-margin 
hyperplane can be found in this space. However, it is not necessary to directly 
define the mapping into the high dimensional space. It is sufficient to compute the 
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Kernel functions (Eq. 2) implicitly map training vectors into a high dimensional 
feature space. The most common kernel functions are linear, polynomial, sigmoid 
and radial basis functions (RBF) kernels. We chose to use RBF kernel (Eq. 3) 
 
! 
K(x, " x ) = exp(#$ || x # " x ||2)  where 
! 
" > 0    (3) 
in our approaches because it is usually more effective and faster in training 
process than the rest of the kernels (Shah and Bork, 2005; Yao et al., 2005; 
Pirooznia and Deng, 2006; Habib et al., 2008; Samui 2008).  
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1.2 Feature Vectors  
 
1.2.1 Overview 
Feature vectors are n-dimensional vectors of numbers, used to represent 
objects. These numerical representations of features are used by Machine 
Learning algorithms in classification of objects. An ideal set of feature 
vectors contains accurate information that is highly informative, leading the 
classifier to an optimal performance. Conversely, ambiguous information 
increases noise level that can negatively affect the final prediction results. 
Hence, understanding of similarities and differences in the data sets used to 
train a classification system is important. The choice of feature vectors 
should be based on scientific knowledge of the systems. In Bioinformatics, 
xamples of feature vectors include physicochemical properties of sequences 
(Cui et al., 2006; Du and Li, 2006), directional shape signatures (Aghili et 
al., 2005), multiple sequence features (Song et al., 2007) and gene 
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1.2.2 Pairwise Sequence Alignment as Feature Vector 
Sequence similarity implies similarity in a three-dimensional structure. Pairwise 
sequence similarity scores reflect residue composition and relative positional 
similarity of a sequence pair. Allergens with similar structures tend to have 
similar epitopes, and thus bind to the same type of IgE, causing cross-reactivity 
(Aalberse, 2000). Similarity among surface epitopes is thus more important than 
that of the whole protein structure for cross-reactive allergen prediction. 
Nevertheless, limited information is available on surface epitopes despite of many 
known allergens. Profiles of pairwise sequence similarity scores differentiate 
potentially important conserved regions for allergen recognition from irrelevant 
conserved regions, through the generalization property of SVM. This approach 
solves a very important problem in cross-reactive allergen prediction - the lack of 
experimentally verified epitope information. The pairwise vectorization 
framework allows the modeling of essential features in allergens that are involved 
in cross-reactivity, but not limited to distinct sets of physicochemical properties. 
Therefore, feature vectors composed of pairwise sequence similarity scores 
should be a good choice for the prediction of allergen cross-reactivity.  
In order to incorporate as much information as possible, a profile of 
similarity scores is used instead of a single pairwise comparison. We construct the 
profiles for each sequence by comparing the sequence to a selected reference 
group of proteins by multiple pairwise sequence alignments. These profiles 
constitute the feature vectors and the selected reference group of proteins is the 
positive training set. 
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SVM-Pairwise is a method that employs pairwise sequence similarity 
scores as feature vectors (Liao and Noble, 2003).  It is based on SVM-Fisher 
(Jaakkola et al., 2000), which is a combination of a profile hidden Markov model 
(HMM) with SVM, altered by Liao and Noble to work with Smith-Waterman 
local alignment algorithm in place of the HMM. SVM-Pairwise has been 
successfully applied to remote homology detection (Liao and Noble, 2003) and 
prediction of subcellular localization of proteins (Kim et al., 2006). 
 
Figure 1.1  - Construction of the feature vectors for samples. Samples are the training, 
testing and independent data sets. Both positive (1) and negative  (2) data sets are 
compared to the reference data set (3) to construct feature vectors (4 and 5). Unlike the 
original SVM-Pairwise, the reference data set (3) used in AllerHunter consists of only the 
positive training data set rather than both positive and negative data sets. 
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We propose a modified SVM-Pairwise method, which we have 
implemented in AllerHunter software to predict cross-reactive allergens. In the 
original version two reference data sets are used, one consisting of positive data 
and the second consisting of negative data. In our application, we assume that the 
negative data is heterogeneous and thus do not possess common features causing 
them to be non-allergens. Therefore, in order to keep the input data coherent, we 
use only a positive reference data set in the training (Figure 1.1). This approach 
has the additional advantage of being faster than the usage of double reference 
sets. The feature vector corresponding to a particular protein X is Fx = ƒx1, ƒx2, … 
, ƒxn, where n is the total number of sequences in the reference data set and ƒxi, is 
the Smith-Waterman alignment score between sequence X and the ith sequence in 
the reference data set (Figure 1.2). 
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Figure 1.2  - Conversion of protein sequence to a feature vector. The feature vector 
corresponding to a particular protein X is Fx = ƒx1, ƒx2, , ƒxn, where n is the total number 
of allergens in the training data set and ƒxi, is the Smith-Waterman alignment score of 
sequence X against the ith allergens in the training data set. 
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1.2.3 Codon Usage Indices as Feature Vector 
Unlike pairwise sequence similarity, codon usage indices generalize sequences 
based on composition of subunits. The codon usage quantity can be assessed by 
the synonymous codon usage frequency. The codon usage is influenced by 
mutational biases and natural selection thus being non-random (Sharp and 
Matassi, 1994; Clarke, 1970). Analysis of codon usage in mammalian, viral, 
bacteriophage, bacterial, mitochondrial and lower eukaryote genes demonstrated 
that genes can be grouped according to codon usage and that these categories 
generally agree with its taxonomic groupings (Grantham et al., 1980a; Grantham 
et al., 1981; Grantham et al., 1980b). The latter discovery lead to the proposal of 
the Genome Theory, which states that the codon usage pattern of a genome is a 
specific characteristic of an organism (Grantham et al., 1980b).  Graham and co-
workers speculated that differences in codon usage are correlated with variation in 
tRNA abundance (Grantham et al., 1980b) needed for control of gene expression 
(Grantham et al., 1981). 
 Based on the Genome Theory, we hypothesize that the differences in 
codon usage can be used to predict the taxonomic group that a particular sequence 
belongs to. We tested codon usage indices as feature vectors, applied to prediction 
viral origin of unknown sequences. We propose a novel method of using codon 
usage indices as feature vectors in support vector machine. The generalization 
property of support vector machine allows the application of codon usage indices 
to distinguish nucleotide sequences of different taxonomic groups.  
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Codon usage indices consist of codon adaptiveness index (CAI) (Sharp 
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where ƒaa,i is the frequency of a codon for amino acid aa, ƒaa,max is the frequency of 
the most frequently used codon encoding for amino acid aa, and ƒtotal is the total 
frequency of all codons in a particular sequence. CAI measures relative 
adaptiveness of the codon usage of a gene towards the codon usage of highly 
expressed genes. CAI is the ratio of the frequency of each individual codon and 
the frequency of the most abundant synonymous codon (Eq. 4). A pseudo-count is 
added to each codon frequency such that no CAI is evaluated to zero. CF of a 
codon is the total frequency of the codon over the total frequency of all codons 
(Eq. 5).  
The term codon usage is of biological significance only to codons in 
coding genes and thus of little relevance to triplets that are non-codons. However, 
viruses have compact genomes where majority of its sequences are coding 
sequences. For example some bacterial genomes and viral genomes such as 
Hepatitis B viruses have overlapping genes in different reading frames (Johnson 
and Chisholm, 2004). Thus, overlapping forward and inverted reading frames 
were used in training and optimization of prediction model to factor in the 
existence of overlapping genes in different reading frames. This removes 
dependency on identifying the reading frame of an unknown sequence. Each 
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nucleotide sequence is represented by two series of 128 dimension feature 
vectors, generated by sliding windows of size 3 along the forward and inverted 
reading frames of the nucleotide sequence. The resulting indices are not the 
conventional CAI and CF values as these indices are generated from the usage of 
non-overlapping codons, opposed to the sliding window method that generates 












Allergy or Type 1 Hypersensitivity is an immunoglobulin E (IgE)-mediated 
allergic reaction caused by allergens. Allergy affects over 20% of the population 
in industrialized countries (Castro et al., 1996; Kay, 1997). Symptomatic 
manifestations include inflammation, itching, coughing, allergic asthma, 
allergenic rhinitis, conjunctivitis, atopic dermatitis, food allergy, anaphylaxis,  
lacrimation, and diarrhoea.  Although genetically modified food helps to alleviate 
the problem of food shortage and high food prices, it also poses a health-risk for 
food allergy. Approximately 5% to 7.5% of children and 1% to 2% of adults are 
known to have some kind of food allergy (Bock 1987; Niestijl et al., 1994). 
Allergens are predominantly proteins, glycoproteins or carbohydrates 
present in substantial amounts over prolonged periods in the patients’ 
environment factor or food (Bredehorst and David, 2000). Sources of protein 
antigens include pollens, mites, animals, insects, moulds and food (Valenta 2002; 
Valenta et al., 2004).  
In 1921, Praustniz and Kustner discovered a factor present in the blood of 
individuals allergic to a particular allergen, which rendered them sensitive to the 
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allergen when transferred to the skin of non-allergic individuals. These 
immunoglobulins are synthesized by B-cells after an initial exposure to an 
allergen. IgE binds to FcεR1 on mast cells in smooth muscle, blood vessels, and 
mucosal linings, causing sensitization of the individual to a particular allergen. 
The binding mechanism of allergens to IgE is based on the IgE recognition 
of epitopes, regions on the surface of the allergen proteins. There are two types of 
epitopes: linear/sequential epitopes i.e. epitopes formed from sequential amino 
acids, and conformation/structural epitopes i.e. epitopes formed from amino acids 
scattered throughout a protein sequence but brought together by protein folding. A 
single allergen has more than one epitope. In sensitized individuals, subsequent 
exposure causes allergens to bind to multiple FcεR1-bound IgEs, resulting in 
cross-linking between IgE receptors on mast cells and basophils. This triggers 
effector cell degranulation and rapid release of stored mediators of allergic 
reactions (e.g. histamines), and secretion of cytokines (Galli et al., 1991). 
Allergens can be assessed based on allergenicity and cross-reactivity. 
Allergenicity refers to the immunogenicity potential of an allergen to induce IgE 
antibodies production and cross-reactivity refers to the potential to bind to IgE 
previously induced by another allergen. Since cross-reactivity requires similar 
protein folds, it is easier to predict than allergenicity, because the specific 
immunological mechanisms required for assessment are still largely unknown 
(Aalberse, 2000).  
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2.1.2 Progress in Cross-Reactive Allergen Prediction 
Prediction of cross-reactive allergens can identify potentially offending agents 
and thus specific precautions can be taken to prevent exposure to such agents. 
Several widely recognized guidelines for allergenicity assessment include the 
scheme devised by International Food Biotechnology Council in collaboration 
with the International Life Sciences Institute (Metcalfe et. al, 1996), the 
FAO/WHO evaluation scheme (FAO/WHO, 2001) and the Codex Alimentarius 
Commission guidelines (Codex, 2003). However, these guidelines may often 
provide conflicting recommendations for allergenicity assessment. Comparison of 
the key elements in these methods show that the Codex guidelines is the most 
suitable candidate for evaluating of allergenicity potential, based on its current 
state of knowledge regarding food allergens and risk (Goodman et. al, 2008). In 
the Codex guidelines the bioinformatics methods are complemented by 
experimental testing. The bioinformatics methods in the Codex guidelines include 
determining whether the gene originated from species known to be a common 
source of allergen and sequence similarity assessment. In addition, a sequence 
match of more than 35 percent identity over 80 amino acids or more than 50 
percent identity to a known allergen is required. These candidates are then 
assessed experimentally by testing for IgE binding, stability and abundance in 
blood sera. The FAO/WHO evaluation scheme involves similar bioinformatics 
guidelines, a criteria of either an exact match of at least six consecutive amino 
acids or more than 35 percent identity over 80 amino acids. However, the 
FAO/WHO scheme has a low precision (Stadler and Stadler, 2003). 
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Recently developed allergen prediction methods demonstrate 
improvement in both sensitivity and specificity. DASARP (Detection based on 
Automated Selection of Allergen-Representative Peptide) makes use of allergen-
representative peptides (ARPs) with low or no occurrences in non-allergens to 
predict cross-reactivity. (Björklund et al., 2005). Björklund and co-workers 
obtained ARPs by comparing peptide fragments in repositories of known 
allergens with putative non-allergens that were selected among commonly 
consumed commodities. 
 APPEL employs SVM and sequence-derived protein structural and 
physicochemical properties as feature vectors (Cui et al., 2005). Cui and co-
workers trained APPEL using known allergens and putative non-allergens. The 
selected putative non-allergens represent protein families with no known 
allergens. The host species of the selected protein families are in wide and 
constant contact with humans in various regions and among ethnic groups, or the 
host has been extensively studied for allergenicity. 
AlgPred combines several prediction methods such as amino acid 
composition, motif-based prediction and the presence of IgE epitopes (Saha and 
Raghava, 2006). AlgPred uses the same data set as DASARP and IgE epitope 
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2.1.3 Limitation of Existing Methods 
Similar protein folds do not warrant cross-reactivity (Aalberse, 2000). Likewise, 
high overall sequence similarity does not necessarily lead to cross-reactivity. 
Thus, allergens cannot be distinguished from non-allergens by simply finding a 
threshold similarity. It is relatively easy to discriminate sequences that are very 
different, but sophisticated methods are necessary for highly similar sequences i.e. 
non-allergens highly similar to allergens are more difficult to distinguish than 
non-allergens that are very different from allergens. So far, the current prediction 
methods are not efficient in distinguishing allergen-like non-allergens and 
allergens. We have developed a novel software tool, AllerHunter that specifically 
addresses this challenge. 
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2.2 Materials and Methods 
 
2.2.1 Overview 
AllerHunter employs a two-class support vector machine. We constructed feature 
vectors by cross-comparison of allergen and non-allergen sequences. These sets 
of alignment scores correspond to the distinguishing features in allergens and 
non-allergens. These scores represent important physicochemical properties 
involved in cross-reactivity, but are not limited to any distinct set of properties.  
One of the main design objectives is to increase the sensitivity and the 
specificity of the method to sequences highly similar to known allergens. 
Therefore, we created two separate putative non-allergen data sets, comprising 
allergen-like putative non-allergens (APN) and divergent putative non-allergen 
(DPN). Separation of the negative data sets enables controlled fine-tuning to 
increase specificity for non-allergen sequences highly similar to known allergens, 
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2.2.2 Data sets 
The allergen sequence data was collected from GenBank (Dennis et al., 2005), 
Swiss-Prot/TrEMBL (Wu et al., 2003), The Allergome Database 
(http://www.allergome.org), The Food Allergy Research and Resource Program 
(http://www.farrp.org), Structural Database of Allergenic Proteins 
(http://fermi.utmb.edu/SDAP), the Allergen Database (http://allergen.csl.gov.uk) 
and by manually curating more than 30,000 journal entries. All duplicates were 
removed. Where data was obtained as a mixture of allergens and non-allergens, 
allergens were identified using the keyword ‘allergen’, and putative allergens 
were removed using keywords ‘putative’ or ‘potential’. The process resulted in 
the collection of 1,405 experimentally verified allergens and 1,072 putative 
allergens.  
Lack of experimentally verified non-allergens makes it difficult to assess 
the performance of prediction programs that require both a positive and negative 
data set. Most methods use sequences selected from protein families that do not 
contain known allergens and having frequent contact with humans of all regions, 
among diverse ethnic groups, alternatively from extensively studied organisms 
with no known derived allergens (Cui et al., 2006; Saha and Raghava, 2006; 
Björklund et al., 2005). Negative data used in AllerHunter consists of all 
sequences from Swiss-Prot database that were not known to be allergens or 
putative allergens as the pool of putative non-allergens for negative data 
collection. To generate the negative data sets, we downloaded 217,551 sequence 
data from UniProtKB/Swiss-Prot Release 49.6 of 2 May 2006. Experimentally 
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verified allergens, putative allergens and masked sequences were removed, 
resulting in 217,171 putative non-allergen protein sequences. The putative 
allergens were divided into two groups: 1. APNs  (8449 sequences). 2. DPNs 
(208,722 sequences) of experimentally verified allergens. This was done aligning 
the sequences to experimentally verified allergens using BLAST. The criteria for 
the APNs: sequence identity ≥ 30% and coverage ≥ 50%. The DPNs: The 
remaining sequences. The length of all the sequences is ≥20 amino acids. The 
training, testing and independent data sets were created in the ratio of 8:1:1 by 
using all the sequences in the APNs, a set of 5,000 randomly selected sequences 
from the DPNs and 1,405 experimentally verified allergens. Putative allergens 
were not included in these data sets.  The data sets are available on the 
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2.2.3 Construction of Feature Vector 
We constructed feature vectors by converting sequences from all data sets to 
pairwise sequence similarity scores as described in section 2.2.2. All alignments 
were performed by using BLASTP in WU BLAST 2.0 released on 10th of May 
2005 (Gish, 1996-2005). Default parameters were used, except ‘postsw’ option, 
which was enabled to perform full Smith-Waterman before BLAST ouput. The 
BLOSUM62 substitution matrix was chosen because it is among the best of the 
available matrices for detecting weak protein similarities (Corpet, 1988).  
LIBSVM version 2.8 was used for the implementation of SVM (Chang and Lin, 
2001). 
 
2.2.4  Measurement of Prediction Performance 
Performance of AllerHunter on the independent data set was measured using 
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Sensitivity is calculated using experimentally verified allergens (Eq. 6), while 
specificities for APNs and DPNs are calculated separately for each group (Eq. 7). 
We also use Matthew’s Correlation Coefficient MCC, because this measure is 
independent of the class sizes and is generally regarded as a good and balanced 
measure for the quality of binary classification. (Eq. 8). MCC ranges from -
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1≤MCC≤1 whereby MCC=1 indicates the best prediction, in which every allergen 
is correctly predicted and only true allergens are predicted. MCC=-1 indicates an 
anti-correlation where not a single allergen is correctly predicted and the largest 
number of incorrect allergens are predicted. MCC=0 indicates a random 
prediction. 
 
2.2.5 Comparison with other methods 
The performances of AlgPred, APPEL, and DASARP in distinguishing APNs 
from allergens were tested using the independent data set of AllerHunter. 
Sequences below length acceptable for AlgPred, APPEL, and DASARP were 
excluded from performance assessments of all methods. The evaluation scheme 
proposed by FAO/WHO was also tested with proteins that were either a match of 
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2.3 Results and Discussion 
 
2.3.1 Performance of AllerHunter 
We tested the performance of AllerHunter by generating predictions on the 
independent data set. This data set consists of 129 experimentally verified 
allergens, 826 APNs and 488 DPNs that were not used in the training. The results 
show that AllerHunter reached 88.4% sensitivity to experimentally verified 
allergens. Since experimentally verified non-allergens do not exist, we measured 
the specificity on the two putative non-allergen independent data sets, APNs and 
DPNs. The results show 91.8% and 100.0% specificity to APNs and DPNs 
respectively. The overall performance of AllerHunter is summarized in Table 2.1. 
The specificity to DPNs is higher than to APNs as expected, because the 
sequences in the DPN data set are very different from known allergens. 
Data set No . of predicted positives 
No. of predicted 
negatives Sn/Sp (%) 
Experimentally verified 
allergens 114 15 88.4 
APNs 68 758 91.8 
DPNs 0 488 100.0 
 
Table 2.1. Performance of AllerHunter measured on the independent data set. The 
prediction results are given as sensitivity for experimentally verified allergens, and 
















2.3.1 Comparative Performance of AllerHunter 
 
We compared the performance of AllerHunter with commonly used prediction 
tools, AllerHunter, AlgPred, APPEL, DASARP and the FAO/WHO evaluation 
scheme. In this comparison, we again used the same independent data set (Table 
2.2).  High specificities to DPNs are expected because highly different sequences 
are usually not cross-reactive. AllerHunter and APPEL show the highest 
specificity in this data set. In particular, AlgPred, DASARP and the FAO/WHO 
evaluation scheme perform poorly with the putative non-allergen data set. This is 
most likely due to an over-optimization for positive prediction such that there is a 
corresponding increase of false positives. Despite the highest sensitivity given by 
the FAO/WHO evaluation scheme, the high number of false positives is 
consistent with previous reports criticizing its loose criteria (Stadler and Stadler, 
2003). Matthew’s correlation coefficient (MCC) calculated for this scheme gave a 
mere 0.001, indicative of near random prediction.  
 
Table 2.2. The comparison of the performance of AllerHunter with common prediction 
methods on the independent data set. The prediction results are given as sensitivity for 
experimentally verified allergens, and specificities for APNs and DPNs. Matthews’ 
correlation coefficients are also calculated. 
 
  
Data set FAO/ WHO AlgPred DASARP APPEL AllerHunter 
Experimentally verified allergens 97.8 92.2 91.0 81.4 88.4 
APNs 0.06 32.9 38.5 90.3 91.7 
DPNs 24.2 57.1 97.6 99.9 100.0 
Matthew’s correlation coefficient 
(MCC) 0.001 0.201 0.298 0.641 0.715 
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Both AllerHunter and APPEL show comparable ability in distinguishing 
non-allergens from allergens among allergen-like sequences, with specificity of 
91.7% and 90.3% respectively. As illustrated in Table 2.2, AllerHunter 
(SE=88.4%, SP=97.6%, MCC=0.715) consistently outperforms all existing 
techniques tested in this study. The predictive performances of AlgPred 
(MCC=0.201) and DASARP (MCC=0.298) is low, suggesting that these systems 
may be over-optimized for positive prediction. Although the FAO/WHO 
evaluation scheme has the highest sensitivity of 97.8%, it also has a low 
specificity (27.9%). This is consistent with existing reports on its inherent 
limitations that its precision may be too low to be of practical use (Tong and 
Tammi, 2008).  
The best two methods in AlgPred are the amino acid composition 
approach, and the hybrid of the latter combined with IgE epitope approach. Both 
methods have an accuracy of about 84% (Saha and Raghava, 2006). Since the 
hybrid method was not available on their website during the period of our project, 












2.3.1 Prediction of Allergen Cross-reactivity in Swiss Prot proteins 
In order to compare the performances of the prediction software on a large data 
set. We predicted allergen cross-reactivity in 217,551 Swiss-Prot proteins 
(Release 49.6). AllerHunter predicted 3537 proteins or 1.6% of Swiss-Prot 
proteins as allergens, less than the other methods. (Table 2.3). The motif-based 
method has a high sensitivity, but a low precision (Stadler and Stadler, 2003). 
Hence, it is likely that the prediction of 4% of Swiss-Prot proteins being allergens, 
is an over-estimation.  
We used Uni-ProtKB/Swiss-Prot Release 46.0 to compare AllerHunter with 
APPEL because sequences in this release were similar to the release used by 
APPEL, which is not available. Although AllerHunter has a higher sensitivity 
than APPEL, 88.4% and 81.4% respectively, it predicted fewer allergens in 
Swiss-Prot. A possible explanation is the slightly higher specificity of 
AllerHunter compared to APPEL, 97.6% and 96.4% respectively. Assuming that 
4% of Swiss-Prot proteins are allergens (Stadler and Stadler, 2003), is an 
overestimation, a conservative gauge of the percentage of non-allergens in Swiss-
Prot should be at least 96%. The small difference in percentage of 1.2 in 
specificity can account for a conservative estimate of 1800 more correctly 
predicted non-allergens. If we reduce the specificity of AllerHunter to match that 
of APPEL, the number of false positives generated will push estimate of allergens 
in Swiss-Prot to around 3.0%, a closer match to the prediction of 2.9% by 
APPEL. As the ratio of allergens to the size of Swiss-Prot is also very low, the 
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higher sensitivity of AllerHunter will not increase the percentage of allergens 
predicted in Swiss-Prot. 
 
 
Method Swiss-Prot release 
Total number of  Swiss-Prot 
proteins compared 
Percentage of Swiss-Prot 
proteins predicted as 
allergens (%) 
Motif-based method 40.0 101,602 4.0 
APPEL Not available 168,128 2.9 
AllerHunter 46.0 168,297 1.8 
AllerHunter 49.6 217,551 1.6 
 
Table 2.3. Percentage of Swiss-Prot proteins predicted as allergens by motif-based 
method, APPEL and AllerHunter. The total numbers of Swiss-Prot proteins used for 





















It has been reported that similarity in protein folds does not necessary lead to 
cross-reactivity between two allergens (Aalberse, 2000). Hence, a single threshold 
of similarity might not be effective for assessing all potential allergenicity. In this 
aspect, AllerHunter considers a profile of pairwise similarities to both allergen 
and non-allergen sequences for inferring the potential allergenicities and allergic 
cross-reactivities in protein sequences. Such a profile of alignment scores 
summarizes the differences between a given sequence and a given family of 
allergen proteins. It has the potential to identify remote relationships in distantly 
related protein sequences, which may not be effectively modeled by existing 
sequence-based computational strategies (Liao and Noble, 2003, Chua and Sung, 
2005). Given the high diversity of allergen sequences, the proposed encoding 
scheme amplifies similarities and differences between allergens and non-allergens 
through the use of a series of sequence identities instead of a universal weighting 
scheme employed by existing techniques. We have shown that the SVM-pairwise 
method consistently outperforms current state-of-the-art algorithms. It has been 
estimated that less than 4.0% of Swiss-Prot proteins were allergens (Cui et al., 
2006; Stadler and Stadler, 2003). As such, after removal of experimentally 
verified allergens and putative allergens, randomly sampled sequences from 
Swiss-Prot have a minimal adverse effect on the predictive performance of 
AllerHunter. To date, the general characteristics of allergens such as structural, 
functional or biochemical properties that explain their ability to elicit allergic 
responses remain unclear (Brusic et al., 2003). Given the complex nature of 
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allergic cross-reactivity, the methodology we propose herein may be useful for 
both the analysis of allergenicity and the better understanding of the biological 






VIRAL SEQUENCE PREDICTION 
 
3.1  Introduction 
Viruses are non-living elementary biosystems that possess certain properties of 
living systems such as the existence of genes and the ability to adapt to a 
changing environment (van Regenmortel, 2000). Replication of viruses occurs 
through the metabolic activities of host cells. Disease caused by viruses range 
from relatively harmless infections such as colds, flu, diarrhea, measles to deadly 
diseases such as yellow fever and acquired immunodeficiency syndrome (AIDS). 
Many diseases still have an unknown etiology.  For example, no etiological agents 
have been found in 12 to 45% of lower respiratory tract infections (LRTI) cases in 
the United States (Juvén et al., 2000; Marre et al., 2000; Rohde et al., 2003; 
Iwane et al., 2004; Jartti et al., 2004). It is likely that there are many human 
diseases caused by unidentified viruses (Relman, 1999).  
In 1884, Charles Chamberland, a microbiologist who worked with Louis 
Pasteur, created an unglazed porcelain filter with pores sufficiently small to filter 
bacteria from solution. This has enabled the creation of sterile media without the 
use of heat. In 1892 however, Dmitrii Ivanowski found that the causative agent of 
the tobacco mosaic disease was able to pass through the Chamberland’s porcelain 
filter. Martinus Beijerinck concluded in 1898 that the particles were too small to 
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be bacteria and were later found to be viruses. In the 1950s, cell culture 
techniques became the standard for isolation, propagation and quantification of 
viruses 
 The identification of viral agents is challenging in particular for the cases 
when the viruses cannot be cultured. For example, certain enteric viruses such as 
noroviruses are known to be unculturable and viruses such as rotaviruses and 
hepatitis A are difficult to cultivate in cell culture systems. Approaches, such as 
simple cloning and recombinant cDNA library construction were early attempts to 
circumvent this problem (Cotmore and Tattersall, 1984; Clewley, 1985; Choo et 
al., 1989). However, these methods are non-specific and time-consuming. The 
introduction of polymerase chain reaction (PCR) techniques enabled specific 
amplification using primers based on known virus sequences (Clewley JP et al., 
1998; Donehower et al., 1990; Wichmann et al., 1992). But these primers were 
only useful to search for specific or similar virus genomes. This limits the 
possible discovery of novel viruses.  
The rapid development of molecular methods enabled the detection 
viruses that are difficult to culture or unculturable viruses (Kellam, 1998; Relman 
1999; Allander et al., 2001; Simmonds 2002). However, the identification of 
viruses in serum and plasma in viral-infected individuals is still today a 
challenging task due to the small amount of viral sequences compared to the 
usually relatively large amount of host genomic sequences. This problem is 
circumvented through the use of a combination of different techniques, such as 
sequence-independent single primer amplification (SISPA) (Reyes and Kim, 
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1991) and random PCR (Froussard, 1992), coupled with selection methods such 
as immuno-screening and subtraction of sequences common to non-infected 
sources (Meurhoff et al., 1997; Palacios et al., 2008). A recent successful method 
to identify novel viruses uses a workflow that combines a filtering technique for 
host DNA depletion, random PCR amplification, large-scale sequencing followed 
by bioinformatics methods (Allander et al., 2005). 
Discovery of novel viruses largely focuses on development of 
experimental methods that specifically target the isolation of novel viral 
sequences from amplified mixture of nucleotide sequences. The isolated 
sequences are then compared to databases for identification through similarity to 
known sequences. Various other sequence similarity-based methods can be used 
to classify sequences in samples. A recent sophisticated method, CARMA is 
based on conserved Pfam domain and protein families (Krause  et al., 2008). 
However, sequences that do not exhibit any similarity to previously known 
sequences cannot be classified by sequence similarity based methods. In order to 
discover novel viruses, it is of particular interest to analyze these unknown 
sequences. The methodic extension of a large number of such sequences by 
design of specific primers and sequencing is costly and time consuming. It would 
be advantageous if the unknown fragments could be classified to yield a set of 
candidate sequences. To our knowledge, no method is currently available for the 
prediction of origins of unknown sequences that lack similarity to known 
sequences. We have developed a method to specifically address this issue. We 
describe the software tool, VIPR, a viral nucleotide sequence prediction method, 
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which complements existing identification methods by suggesting a potential viral 
origin of sequences in samples. 
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3.2 Materials and Methods 
 
3.2.1   Overview 
VIPR uses the same two-class SVM engine as AllerHunter. We created feature 
vectors using CAI (Eq. 4) and CF (Eq. 5). One of the main design objectives is to 
construct a prediction program independent of the knowledge of the reading 
frame of an unknown sequence, because virus sequences often contain 
overlapping reading frames. Therefore, overlapping reading frames of both 
forward and inverted reading frames were used to generate feature vectors.  
 
3.2.2 Data sets 
Data set used for VIPR model optimization and testing consists of nucleotide 
sequences of virus, bacteria and human, downloaded from NCBI-GenBank Flat 
File Release 151.0 (Benson et al., 2000). These data sets contain 155,006 virus 
sequences used as positives, 618,870 bacterial sequences and 27,880 human 
sequences used as negative data. We chose to use bacterial and human data as the 
negative data set, because samples from humans are anticipated to contain not 
only human, but also many bacterial sequences. We created the training and 
testing data sets, consisting of 15,000 sequences each in each set. This was done 
by randomly choosing 5,000 sequences from each of data set in the downloaded 
data. The remaining sequences were used for the preparation of two independent 
data sets: IDS-A and IDS-B. IDS-A contains in total 15,000 sequences, collected 
by randomly choosing 5,000 sequences from each of the three downloaded data 
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sets. For the purpose of testing the performance of VIPR on varied sizes of 
sequence fragments, we constructed a second independent data set, IDS-B, 
containing the total of 8,886,000 fragments of varied sizes, 2,000 of each size 
from each of the remaining downloaded data sets. We created these fragments by 
randomly selecting a starting location and extracting all sizes of fragments from 
20 to 1,500 of length.  
 
3.2.3   Construction of Feature Vectors 
We constructed feature vectors by converting sequences from all data set to codon 
usage indices as described in section 2.2.3. LIBSVM version 2.8 was used for the 
implementation of SVM (Chang and Lin, 2001).  
 
3.2.4 Measurement of Prediction Performance 
Performance of VIPR on the independent data set was measured with the same 
method as the measurement of performance of AllerHunter, stated in section 
2.2.4. 
Sensitivity was calculated using viral sequences independent data set (Eq. 6) 
while specificity was calculated using the combined bacterial and human 
sequences independent data set (Eq. 7).  MCC value was also calculated (Eq. 8). 
MCC ranges from -1≤MCC≤1 whereby MCC=1 indicates the best prediction, in 
which every virus sequence is correctly predicted and only true virus sequences 
are predicted. MCC=-1 indicates an anti-correlation where not a single virus 
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sequence is correctly predicted and the largest number of incorrect virus 
sequences are predicted. MCC=0 indicates a random prediction. 
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3.3 Results and Discussion 
 
3.3.1 Performance of VIPR 
We assessed the overall performance of VIPR by testing on the independent data 
set IDS-A, containing the full-length sequences. In order, to assess the 
performance of the varied fragment sizes, we run prediction on the independent 
data set, which contains varied fragment sizes, IDS-B. The results on the IDS-A 
show 90.5% sensitivity, 94.1% specificity and MCC value of 0.80 (Table 3.1). 
The results from the test on the varied sequence lengths, on the data set IDS-B, 
show that the performance is very good on sequence lengths longer than 100 
residues, sensitivity varying between ~70% and ~85%. Below this threshold the 
sensitivity decreases drastically. The prediction specificity is almost constant 
~90% over the measured lengths (Figure 3.1).  
 




131294 13712 589906 36834 90.544 94.123 0.80121 
Table 3.1. Performance of VIPR measured on the independent data set, IDS-A, 









Figure 3.1. Performance of VIPR to various nucleotide length measured on the second 
independent data set, IDS-B that contains varied lengths of sequences. 
 
3.3.2 Codon Usage Indices 
We included inverted reading frames into the training model, since many viruses 
contain reading frames on both strands. Although, most of these sequences are not 
made up of codons coding for gene sequences and thus lack specific patterns of 
codon usage due to the lack of evolutionary pressure, we assume that this will not 
have a significant negative impact on the performance. This is because only 
distinguishing features that form the support vectors close to the decision 
boundary in SVM are involved in hyperplane computation. The high sensitivity 
and specificity shown in the results, support this assumption.  We did not 
specifically focus on known open reading frames because the prediction method 
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has to be able to classify unknown sequences independent of the knowledge of its 
reading frame.  




We have constructed a novel method to predict viral origins of unknown 
sequences. Application of codon usage indices as feature vectors in SVM forms 
an efficient generalization of codon usage properties of viral sequences. VIPR is 
able to predict the potential viral origin of sequences longer than 100 residues 
with sensitivity varying between ~70% and ~85%, and specificity of ~90%. These 
results show that VIPR is an efficient tool to complement existing molecular viral 
discovery methods such as the high-throughput 454 sequencing method, which is 
capable of generating average read length of 250bp (Marguilies et al., 2005). A 
lot of time and effort can be saved, by allowing focused sequencing of only 
interesting candidates, pinpointed by VIPR. 
 VIPR is specifically trained using sequences from human, bacteria and 
viruses in order to optimize its performance for the prediction of viral origin of  
sequences in diseased human samples. The method of utilization of codon usage 
indices coupled with SVM may easily be generalized. When trained with 
appropriate data sets, the method used in VIPR can for example be employed in 






In this thesis, I have described two novel methods. 1. the combination of sequence 
similarity scores with SVM, and 2. the use of codon usage indices with SVM. 
Firstly, the implementation of the combination of sequence similarity 
scores with SVM was achieved. The novel usage of two separate negative training 
sets, one consisting of divergent data and one consisting of allergen-like data, 
yields a good prediction performance in particular on allergen-like data. In 
general, it should be relatively easy to distinguish very divergent objects as 
opposed to the task of classifying very similar objects. For this reason, even a 
simple algorithm may achieve quite good overall performance. However, in order 
to approach near 100% performance, sophisticated methods are required, because 
it requires the classification of similar objects. We have achieved this by using 
two distinct negative training sets. Pairwise sequence similarity was chosen as 
feature vectors in the prediction of cross-reactive allergens because it accounts for 
a profile of similarities of proteins across a set of diverse allergens. It is important 
that this feature is able to distinguish conserved features among allergens, and 
among non-allergens, which is potentially important for IgE recognition. Results 
show that pairwise sequence similarity is a suitable candidate as feature vectors 
for cross-reactive allergen prediction.  
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Secondly, the method of codon usage indices for efficient prediction of 
potential viral origin of unknown sequences that lack similarity with known 
sequences. This method is implemented in VIPR software. Codon usage indices 
were chosen based on the hypothesis that there are fewer differences in codon 
usage between species within the same taxonomic group than species from other 
groups. Codon usage indices coupled with SVM, generalizes properties in viral, 
human, and bacterial nucleotide sequences to predict novel viral sequences. 
Results show that codon usage indices are suitable candidate as feature vectors for 
viral sequence prediction. The results agree with our hypothesis that the 
difference in codon usage in different species can be used to predict the origin of 
sequences. The method can be generalized for other applications. To the best of 
our knowledge, this is the first time the codon usage indices have been applied for 
this purpose. 
The results show that we have effectively applied the generalization 
property of SVM to the prediction of cross-reactive allergens and viral sequences. 
The choice of feature vectors that can distinguish between two classes of data is 
important to determine the prediction performance because it ascertains the 
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